SUTRO BIOPHARMA
Sutro Biopharma is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
SUTRO BIOPHARMA
Industry:
Biotechnology Information Technology Medical
Founded:
2003-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.sutrobio.com
Total Employee:
251+
Status:
Active
Contact:
650-392-8412
Total Funding:
636.61 M USD
Technology used in webpage:
Domain Not Resolving LetsEncrypt IPv6 Microsoft CloudFront PostalAddress Schema Amazon Frankfurt Region Google Analytics Event Tracking Browser-Update Corporation Schema
Similar Organizations
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Stonehage Fleming Family & Partners
Stonehage Fleming Private Equity has been rebranded FPE Capital.
Midwest Bioprocessing Center
Midwest Bioprocessing Center is a pioneer in glycochemical bioprocess technology.
Neurimmune Holding
Neurimmune develops innovative immunotherapeutics for human diseases.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Sectra
Sectra is a company that creates and sells products in secure communication and medical information technology.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Willow Industries
Willow Industries is the leader in cannabis & hemp decontamination technology.
Current Advisors List
Board_member
Board_member
2007-12-01
Board_member
2018-11-01
Board_member
2018-07-01
Advisor
Board_member
2009-01-01
Board_member
2009-01-01
Board_member
2017-02-01
Current Employees Featured
Trevor Hallam President, Research & Chief Scientific Officer @ Sutro Biopharma
President, Research & Chief Scientific Officer
2021-04-01
Jane Chung President and Chief Operating Officer @ Sutro Biopharma
President and Chief Operating Officer
Brunilda Shtylla VP Business Development @ Sutro Biopharma
VP Business Development
2020-01-01
James R. Swartz Founder & Director @ Sutro Biopharma
Founder & Director
Henry Heinsohn VP Process Development @ Sutro Biopharma
VP Process Development
2008-03-01
Nicki Vasquez SVP Alliance Management/Portfolio Strategy & Operations @ Sutro Biopharma
SVP Alliance Management/Portfolio Strategy & Operations
Heidi Hoffmann Senior Director, Supply Chain and CMC Team Lead @ Sutro Biopharma
Senior Director, Supply Chain and CMC Team Lead
2016-04-01
Craig Berman VP Clinical @ Sutro Biopharma
VP Clinical
Regina Cheng VP, Finance and Controller @ Sutro Biopharma
VP, Finance and Controller
Annie Chang Vice President of Investor Relations @ Sutro Biopharma
Vice President of Investor Relations
2020-01-01
Founder
Stock Details
Investors List
Blackstone Life Sciences
Blackstone Life Sciences investment in Post-IPO Debt - Sutro Biopharma
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Sutro Biopharma
Vida Ventures
Vida Ventures investment in Series E - Sutro Biopharma
Samsara BioCapital
Samsara BioCapital investment in Series E - Sutro Biopharma
Merck
Merck investment in Series E - Sutro Biopharma
Skyline Ventures
Skyline Ventures investment in Series E - Sutro Biopharma
Lilly Ventures
Lilly Ventures investment in Series E - Sutro Biopharma
Centene
Centene investment in Series E - Sutro Biopharma
Celgene
Celgene investment in Series E - Sutro Biopharma
SV Health Investors
SV Health Investors investment in Series E - Sutro Biopharma
Key Employee Changes
Official Site Inspections
http://www.sutrobio.com Semrush global rank: 2.36 M Semrush visits lastest month: 8.26 K
- Host name: ec2-34-211-233-150.us-west-2.compute.amazonaws.com
- IP address: 34.211.233.150
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Sutro Biopharma"
About | Sutro Biopharma, Inc.
About Sutro Biopharma. Sutro is dedicated to transforming the lives of cancer patients by creating medicines with improved therapeutic profiles for areas of unmet need.See details»
Sutro Biopharma - Wikipedia
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Bi…See details»
About Sutro | Sutro Biopharma, Inc.
Dedicated to transforming the lives of cancer patients by creating medicines with improved therapeutic profiles for areas of unmet need. To date, Sutro’s platform has led to ADCs, …See details»
Company Information :: Sutro Biopharma, Inc. (STRO)
For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com. Industry Classifications. Sector. Healthcare. Industry. Biotechnology. NAICS. Research and …See details»
Sutro Biopharma, Inc. | LinkedIn
Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for …See details»
Management Team :: Sutro Biopharma, Inc. (STRO)
From 2018 to 2022, Hans-Peter served as CSO and SVP of 3T Biosciences, where he built up the research organization to over 30 FTEs. He oversaw target identification, platform- and …See details»
Sutro Biopharma - Crunchbase Company Profile & Funding
Organization. Sutro Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
Corporate Governance :: Sutro Biopharma, Inc. (STRO)
Mr. Newell currently serves on the boards of directors of Biotechnology Innovation Organization’s (BIO) Health Section, Emerging Company Section and is a member of BIO’s executive …See details»
Sutro Biopharma, Inc. (STRO) Company Profile & Overview - Stock …
Nov 29, 2024 Sutro Biopharma, Inc. operates as a clinical-stage oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that …See details»
Sutro Biopharma, Inc - BioSpace
Nov 14, 2024 For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com. AWARDS. 111 Oyster Point Blvd South San Francisco, CA 94080 . Tel: …See details»
Sutro Biopharma - Craft
Oct 29, 2024 Sutro Biopharma has 5 employees at their 1 location and $153.73 m in annual revenue in FY 2023. See insights on Sutro Biopharma including office locations, competitors, …See details»
Working At Sutro Biopharma: Company Overview and Culture
Mar 14, 2024 www.sutrobio.com. Organization Type. Public. Social Media. Sutro Biopharma is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged …See details»
Sutro Biopharma, Inc. (STRO)
Nov 1, 2024 For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com. View Management Team View Board of Directors. Stock Snapshot. IR …See details»
Corporate Presentation | Sutro Biopharma, Inc.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you …See details»
Board of Directors :: Sutro Biopharma, Inc. (STRO)
Joseph M. Lobacki has served as a member of our Board of Directors since February 2017. From January 2020 to January 2024, Mr. Lobacki served as President and CEO of Artax a private …See details»
Leadership Team | Sutro Biopharma, Inc.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you …See details»
Sutro Biopharma Reports Second Quarter 2024 Financial Results, …
Aug 13, 2024 Webcasts of the presentations will be accessible through the News & Events page of the Investor Relations section of the Company’s website at www.sutrobio.com. Archived …See details»
Pipeline | Sutro Biopharma, Inc.
Sutro technology is driving the development of novel antibody-drug conjugates, vaccine therapy, immunotherapy, and groundbreaking immunostimulatory ADCs.See details»
Sutro Biopharma Reports Full Year 2022 Financial Results, Business ...
Mar 30, 2023 (1) The condensed balance sheet as of December 31, 2022 was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K for the …See details»